Diabetes Market Competition Heats Up

A global population of patients with prediabetes that is three times the number of those with type 2 diabetes has led to intense competition between drug makers to treat the disease, according to a new report. The "Analysis of the Global Type 2 Diabetes Therapeutic Market" found that 15 new drugs are in late-stage clinical trials or awaiting regulatory review. The report asserts that a "tremendous" increase in type 2 diabetes is in store, and the industry needs better ways to prevent the disease from progressing including identifying the precursors. Frost & Sullivan life sciences, Aug. 2013